Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia

Cancer - United States
doi 10.1002/cncr.26303
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Prognostic Role of CD4 T-Cell Depletion After Frontline Fludarabine, Cyclophosphamide and Rituximab in Chronic Lymphocytic Leukaemia

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies

Therapeutic Advances in Hematology
Hematology
2016English

Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine

Cancer Management and Research
Oncology
2015English

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia

Clinical Cancer Research
Cancer ResearchOncology
2012English

Waldenstrom Macroglobulinemia Presenting as Plasma Cell Leukemia Associated With Hyperviscosity Syndrome

Medical Science and Discovery
2018English

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia

Clinical Cancer Research
Cancer ResearchOncology
2012English

Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing–Neel Syndrome

Case Reports in Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy